Hosking MP, Shirinbak S, Omilusik K, Chandra S, et al. Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy. Cell Stem Cell 2025 May 30:S1934-5909(25)00187.
PMID: 40472844